Skip to content
Medical Health Aged Care, Research Development


La Trobe University 2 mins read
Research leaders Dr Quynh Nhu Dinh and Dr Michael De Silva

For immediate release
31 January 2024

Scientists from La Trobe University and the Hudson Institute have demonstrated that cells from placentas could have therapeutic benefits for patients suffering from high blood pressure.

The research, led by La Trobe Senior Lecturer in Physiology and Pharmacology, Dr Michael De Silva, and published in Scientific Reports, has advanced La Trobe’s recent studies into using placenta cells for stroke recovery, has passed human safety trials.

In the next phase, this new therapy will be assessed for its efficacy at reducing disability caused by stroke, pending Therapeutic Goods Administration approval.

“Here we have built on the groundbreaking results of La Trobe’s previous studies using these cells in stroke models,” Dr De Silva said. “If infused within a day after a stroke, the cells target the affected area of the brain, and reduce inflammation and nerve cell death."

“We realised that we could test if similar protection could be seen in reducing the damage high blood pressure causes in the body and we found that the treatment reduced inflammation in blood vessels," Dr De Silva said.

High blood pressure, also known as hypertension, is the leading cause of strokes and heart attacks, and over time creates inflammation in the arteries and can lead to vascular dementia. More than one in every three Australians over the age of 18 has high blood pressure.

The research team at La Trobe led by Dr Michael De Silva, Dr Quynh Nhu Dinh, and Professor Chris Sobey found that the cells, collected by the Hudson Institute from placentas donated by mothers after caesareans, reduced inflammation and prevented cognitive impairment.

"Blood pressure control rates are at an alarmingly low level of 32 per cent in Australia. While a drug can reduce high blood pressure, these cells could target inflammation in the arteries caused by hypertension and therefore reduce the associated risks of cardiovascular disease and cognitive impairment," Dr De Silva said.

Dr De Silva said while the research was in its early stages and the team would continue to work on how this knowledge may benefit patients with high blood pressure, he was satisfied to see that this research could eventually lead to a new form of therapy that reduced damage to blood vessels and the brain when blood pressure was high.

For further interviews, contact Sue Smethurst:, 0418 643 520


More from this category

  • Medical Health Aged Care
  • 27/02/2024
  • 23:07
Monopar Therapeutics Inc.

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that the internationally recognized radiopharmaceutical physician, Professor Rodney Hicks, will be the lead investigator for Monopar’s MNPR-101-Zr Phase 1 dosimetry clinical trial in advanced cancer patients. Professor Hicks will enroll patients at the Melbourne Theranostic Innovation Centre (MTIC) and will use one of the world's most sensitive clinical total-body PET/CT (positron emission tomography–computed tomography) scanners, the Siemens Biograph Vision Quadra, to image the targeting ability of MNPR-101-Zr in cancer patients.“We are very excited…

  • Indigenous, Medical Health Aged Care
  • 27/02/2024
  • 14:26
Institute for Urban Indigenous Health

Reduction in Indigenous newborn removals by child protection services

Australian research published this month shows women who received care through an innovative Indigenous-led model of maternity care were three times less likely to have their Indigenous newborn removed by child protection services than women who received standard maternity care. The research lands at the same time as the Australian Government’s Closing the Gap 2023 Annual Report which shows the rate of over-representation of Indigenous children in out-of-home care in Australia continues to increase. Kristie Watego, Birthing in Our Community (BiOC) Service Development Manager, Institute for Urban Indigenous Health (IUIH), said the results show it is possible to significantly reduce…

  • Medical Health Aged Care
  • 27/02/2024
  • 09:31
Dementia Australia

Come walk or jog with us in Perth. We are in this together!

The 2024 Perth Memory Walk & Jog is nearly here with the event taking place on Sunday 17 March at Burswood Park, Burswood. Dementia Australia’s largest fundraising event hopes to attract thousands of people across Australia to help raise more than $2 million in support of people living with dementia. Funds raised at our upcoming event in Perth will help advance the work of Dementia Australia which delivers invaluable support, education and resources for people living with dementia, their families and carers. Memory Walk & Jog is about being part of the community and feeling supported. We are in this…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.